OPERATION HADIN KAI FOILS MASS ABDUCTION ATTEMPT AT FGGC MONGUNO. (PHOTOS). #PRESS RELEASE

Image
 PRESS RELEASE OPERATION HADIN KAI FOILS MASS ABDUCTION ATTEMPT AT FGGC MONGUNO Troops of Operation HADIN KAI (OPHK), in collaboration with personnel of the Nigeria Police Mobile Force (MOPOL), successfully foiled an attempted mass abduction by ISWAP terrorists at the Federal Government Girls College (FGGC), Monguno, at about 0130 hours (1:30 a.m.) on 19 July 2026. The FGGC facility is currently being utilized by the Borno State Government as temporary hostel accommodation for students of the Federal Polytechnic, Monguno. The terrorists reportedly gained access to the facility with the assistance of suspected collaborators in an attempt to abduct students. Alert security personnel immediately engaged the terrorists with coordinated and overwhelming firepower, effectively stalling their advance with Sector 3 Quick Reaction Force (QRF) immediately reinforcing the school. Confronted by the superior combat capability and determined resistance of the security forces, the terrorists were...

GSK SEEKS APPROVAL FOR WORLD'S FIRST MALARIA VACCINE.

A jogger runs past a signage for pharmaceutical giant GlaxoSmithKline (GSK) in London April 22, 2014. REUTERS/Luke MacGregor            According to sources,the company Glaxo Smith Kline {GSK} said today thursday that it is applying for regulatory approval for the world's first vaccine against malaria,designed for children in Africa.The British drugmaker said the shot called RTS,S,is intended exclusively for use outside the European union but will be evaluated by the European medicines Agency {EMA} in collaboration with World Health Organisation {WHO}.Malaria,a mosquito borne parastic disease,kills more than 600,000 people a year,mainly babies in the poorest parts of sub Saharan Africa.Experts have long hoped that scientists would be able to develop an effective vaccine against the disease,and scientists at GSK have been working on this one for 30 years.The WHO,has previously indicated it may recommend use of RTS,S from as early as 2015 if EMA drugs regulators back its license application.GSK has been developing RTS,S with the non profit PATH malaria vaccine initiative {MVI},with grant funding from the Bill and Melinda Gates foundation to MVI.The vaccine also contains an adjuvant,or booster,made by U.S biotech company Agenus,which received an undisclosed milestone payment for the regulatory submission.

Comments

Popular posts from this blog

INNOSON GIVES OUT BRAND NEW IVM G5 AND SALARY FOR LIFE TO THE MAN WHO PROPHESIED ABOUT HIS VEHICLE MANUFACTURING IN 1979.(PHOTO).

SHAKIRA COVERS WOMEN'S HEALTH MAGAZINE,APRIL ISSUE.

THE NEW OONI OF ILE-IFE,WILL NOT EAT THE HEART OF THE LATE OONI-PALACE CHIEFS.